top of page
Writer's picturedrpallamon

How does Semaglutide work?

Semaglutide ( brand names Ozempic, Rybelsus, and Wegovy) is a GLP-1 medication. It is a medication that works activating GLP-1 receptors and mimicking the incretin hormones that your body naturally produces when you eat food.


Incretin hormones are gut hormone signals released by the small intestine that travel throughout the body, signaling the brain, endocrine system, and gastrointestinal system that food has been consumed and is ready to be metabolized by the body for fuel. This results in a complex cascade of signals that work together to communicate feelings of fullness.


GLP-1 (glucagon-like peptide-1) is one such incretin hormone, but it does more than just influence satiety: It also plays an important role in the management of blood sugar levels by regulating insulin and glucagon levels. The medication


is prescribed for people living with impaired glucose tole

rance, prediabetes, or diabetes to lower their blood sugar.


As a GLP-1 receptor agonist ( or activator), these medications act by imitating the effects of the GLP-1 hormone produced naturally in your body. In those with type-2 diabetes, prediabetes, or those living with overweight/obesity, natural GLP-1 production may be lower or less effective than normal.

This medication must be used in combination with other tactics to support metabolic health avoid weight regain. These tactics may include modifications to what you eat, how and when you exercise, and other healthy lifestyle changes.


By learning to eat more whole foods and fewer processed carbohydrates, improving sleep quality, participating in moving your body, and managing stressors, you’re setting up both your mind and body for real results. With this foundation in place, the medications can work even more effectively to reduce high blood sugar, increase your body's sensitivity to insulin, and help you lose weight.

source: https://www.joincalibrate.com/resources/ozempic-foods-to-avoid-while-taking-semaglutide


46 views0 comments

Comments


bottom of page